tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ABCL is currently covered by 2 analysts with an average price target of $5.67. This is a potential upside of $7.09 (-55.21%) from yesterday's end of day stock price of $12.66.
Abcellera Biologics 's activity chart (see below) currently has 29 price targets and 24 ratings on display. The stock rating distribution of ABCL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 44.51% with an average time for these price targets to be met of 166.95 days.
Highest price target for ABCL is $9, Lowest price target is $4, average price target is $5.67.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 06-Aug-2026.
Currently out of the existing stock ratings of ABCL, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2021
$9
$-3.63 (-28.74%)
$7
1 months 15 days ago
(06-Aug-2026)
4/8 (50%)
$2.47 (37.83%)
377
Buy Since 07-Jul-2025
$4
$-3.38 (-45.80%)
$5
10 months 14 days ago
(07-Nov-2025)
2/2 (100%)
$0.09 (2.30%)
9
Hold Since 05-Nov-2024
1 years 1 months 8 days ago
(13-Aug-2025)
0/3 (0%)
$6.55 (120.18%)
Buy Since 05-Dec-2023
$10
$2.62 (35.50%)
$5
1 years 2 months 7 days ago
(14-Jul-2025)
7/9 (77.78%)
$5.76 (135.85%)
458
Buy Since 16-May-2025
$10
$2.62 (35.50%)
1 years 4 months 5 days ago
(16-May-2025)
0/1 (0%)
$7.97 (392.61%)
What is ABCL (Abcellera Biologics ) average time for price targets to be met?
Which analyst most recently updated their price target on ABCL (Abcellera Biologics )?
Which analyst has the most public recommendations on ABCL (Abcellera Biologics )?
Which analyst is the currently most bullish on ABCL (Abcellera Biologics )?
Which analyst is the currently most reserved on ABCL (Abcellera Biologics )?
